For the Inventor, By the Inventor

Enter assignee name

Capitalbio Corporation

USPTO Granted Patents = 65

% Expired Patents = 30.8

CIPO Patents = 3

EPO Patents = 21

Trademarks = 1

Forward Citations = 178

Loading Chart...

Loading Chart...

153 inventors (with patents filed for the assignee):

Jing Cheng (54 out of 96 patents)

Wanli Xing (23 out of 27 patents)

Lei Wang (14 out of 581 patents)

4. Dong Wang (9 out of 138 patents)

5. Guoliang Huang (8 out of 10 patents)

6. Xianhua Wang (8 out of 11 patents)

7. Guanbin Zhang (6 out of 8 patents)

8. Huafang Gao (6 out of 7 patents)

9. Xiang Chen (5 out of 22 patents)

10. Liang Bai (5 out of 7 patents)

11. Guangxin Xiang (5 out of 8 patents)

12. Kaijun Zhao (5 out of 5 patents)

13. Xinying Zhou (5 out of 6 patents)

14. Cheng Chen (4 out of 34 patents)

15. Min Guo (4 out of 8 patents)

Core Competencies:

Microfluidic Chip

Biological Detection

Nucleic Acid Extraction

Fluorescent Magnetic Nanoparticles

Cell Isolation

Microarray Devices

Fluid Dispensing

Optical Systems

Centrifugal Separation

PCR Amplification

Biochemical Detection

Sample Preparation

65 patents: Sort by Forward Citations

1. 12544755 - Whole-process biological detection device (2026-02-10),

2. 12297425 - Nucleic acid extraction composition, reagent and kit containing the same and use thereof (2025-05-13),

3. 12227790 - Solid phase extraction material and its use for nucleic acid enrichment and detection (2025-02-18),

4. 11666911 - Sample extraction chip and biological reaction device (2023-06-06),

5. 11577240 - Liquid storage and controlled-release device and biological detection chip (2023-02-14),

6. 11565255 - Valve system for driving fluid and method for using the same (2023-01-31),

7. 11396020 - Integrated microfluidic device for target amplification and microarray detection (2022-07-26),

8. 11396013 - Integrated microfluidic chip and methods of use (2022-07-26),

9. 11268631 - Microfluidic valve and a chip or system comprising the microfluidic valve (2022-03-08),

10. 10885673 - Method for identifying a unit using a camera (2021-01-05),

11. 10758903 - Microfluidic devices for multi-index biochemical detection (2020-09-01),

12. 10704092 - Detection methods based on sequencing (2020-07-07),

13. D869684 - Isothermal amplification microfluidic chip nucleic acid analyzer (2019-12-10),

14. 10365213 - Reliable fluorescence correction method for two-color measurement fluorescence system (2019-07-30),

15. 10309977 - Device for detecting and/or analyzing bio-chip (2019-06-04),

Company Overview

Capitalbio Corporation, headquartered in Beijing, specializes in the development and manufacturing of advanced microfluidic devices. The company focuses on innovative technologies such as microfluidic chips, biological detection systems, and nucleic acid extraction methods. Its expertise extends to the use of fluorescent magnetic nanoparticles, cell isolation techniques, and microarray devices, enhancing capabilities in fluid dispensing and optical systems. Capitalbio aims to advance the field of biotechnology through its cutting-edge solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

65 Patents

#88 in Beijing

#502 in China

#11,344 in the World

Capitalbio Corporation

Forward Citations = 178

153 inventors:

Jing Cheng (54 out of 96 patents)

Wanli Xing (23 out of 27 patents)

Lei Wang (14 out of 581 patents)

4. Dong Wang (9 out of 138 patents)

5. Guoliang Huang (8 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Capitalbio Corporation. Retrieved from https://idiyas.com/company/capitalbio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…